AMGN compared with CGTX: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

CGTXCognition Therapeutics Inc

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

CGTXCognition Therapeutics Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

CGTX: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only CGTX 9

—Lincoln Park Capital Fundunlistedsupplier

—National Institute of Aging (the "NIA")unlistedsupplier

—National Institute on Aging (NIA)unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—NIA Grantsunlistedsupplier

5 more · CGTX chain ›

Price

rebased to 0%

AMGN, solidCGTX, dashed

AMGNAmgen Inc

479.97▲+0.31%

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

CGTXCognition Therapeutics Inc

0.65▼−5.56%

Regular sessionNov 5 '26

Mkt cap$65.0MRevenue—Revenue—

Compare

Regular sessionNov 5 '26

AMGNAmgen Inc

CGTXCognition Therapeutics Inc

479.97▲+0.31%

Price

0.65▼−5.56%

$258.8B

Mkt cap

$65.0M

Q3 FY26$10.4B

Revenue

—

FY25$36.8B

Revenue

—

AMGN479.97▲+0.31%vsCGTX0.65▼−5.56%Regular sessionNov 5 '26